06 May 2022 Ziphius Vaccines and Ghent University publish promising data from self-amplifying RNA platform in Molecular Therapy Member news
04 May 2022 New study led by Memorial Sloan Kettering Cancer Center (NY, US) shows Idylla™ GeneFusion Assay enables more rapid screening of targetable fusions compared to routine methods Member news
03 May 2022 reMYND’s novel Alzheimer program reports excellent brain exposure and safety profile in Phase 1; transitioning into Phase 2a Member news
27 Apr 2022 Kantify and I-Stem Use Artificial Intelligence to discover a promising therapy against a rare disease Member news
26 Apr 2022 Mithra CDMO announces collaboration with MedinCell for the development of injectable products for Malaria and transplant rejection Member news
05 Apr 2022 Sequana Medical announces the completion of alfapump implantations in POSEIDON, the North American pivotal alfapump study Member news
05 Apr 2022 Aligos Therapeutics selects drug candidate ALG-097558, a potent ritonavir-free oral protease inhibitor for the treatment and prevention of COVID-19 Member news
29 Mar 2022 eTheRNA Manufacturing announces new LNP formulation development and production service Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
